TP53 and hepatocellular carcinoma: To further explore the impact of TP53 mutation on the intratumoral microbiota, we divided the samples into TP53 mutation and wild‐type group and conducted a PCoA analysis on HCC (Figure 6a) and EC (Figure 6b).